tirzepatide podcast Semaglutide VS | The Gillett Health #76 The Curbsiders Internal Medicine Podcast
Description
doi: 10.1016/j.bmc.2024.117630, PMID: [DOI] [PubMed] [Google Scholar] 19.Morningstar M, Kolodziej A, Ferreira S, Blumen T, Brake R, Cohen Y
In the presence of MAOIs, phentermine and other drugs that cause release of norepinephrine induce severe cardiovascular and cerebrovascular responses
Introducing semaglutidea medication initially developed to manage diabetes, which is now showing promising results for weight loss
Recent advances in PET imaging and fluid biomarkers are improving monitoring of GLP-1RA treatment response [65]
Women with obesity seeking IVF found to be 47% more likely to conceive naturally after weight loss
